Monopar Therapeutics (MNPR) Exchange Rate Effect (2018 - 2025)
Monopar Therapeutics (MNPR) reported Exchange Rate Effect of $99495.0 for Q4 2025, up 2716.22% on a YoY basis from $3532.9 in Q4 2024, and up 26361.44% sequentially from $376.0 in Q3 2025.
Monopar Therapeutics (MNPR) Exchange Rate Effect (2018 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 8 years of Exchange Rate Effect data on file, last reported at $99495.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 2716.22% year-over-year to $99495.0; the trailing twelve-month figure through Dec 2025 stood at $97266.0 (up 19589.47% YoY), and the FY2025 full-year result was $97266.0, up 19589.47% from the prior year.
- Exchange Rate Effect rose to $99495.0 in Q4 2025, from $376.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $99495.0 in Q4 2025 to a low of -$48687.0 in Q4 2022.
- A 5-year average of $4105.5 and a median of -$23.0 in 2021 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 313750.0% in 2022, while the deepest fall reached 2556.46% in 2022.
- Tracing MNPR's Exchange Rate Effect over 5 years: stood at $1982.0 in 2021, then tumbled by 2556.46% to -$48687.0 in 2022, then surged by 82.84% to -$8357.0 in 2023, then soared by 54.49% to -$3803.0 in 2024, then soared by 2716.22% to $99495.0 in 2025.
- Business Quant data shows MNPR's Exchange Rate Effect at $99495.0 in Q4 2025, $376.0 in Q3 2025, and -$2551.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - | 99,495.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,495.00 |
| Dec 31, 2025 | 99,495.00 |
| Sep 30, 2025 | 376.00 |
| Sep 30, 2025 | 376.00 |
| Jun 30, 2025 | -2,551.00 |
| Jun 30, 2025 | -2,551.00 |
| Mar 31, 2025 | -54.00 |
| Mar 31, 2025 | -54.00 |
| Dec 31, 2024 | -3,803.00 |
| Dec 31, 2024 | -3,803.00 |
| Sep 30, 2024 | 4,457.00 |
| Sep 30, 2024 | 4,457.00 |
| Jun 30, 2024 | 1,492.00 |
| Jun 30, 2024 | 1,492.00 |
| Mar 31, 2024 | -1,652.00 |
| Mar 31, 2024 | -1,652.00 |
| Dec 31, 2023 | -8,357.00 |
| Dec 31, 2023 | -8,357.00 |
| Sep 30, 2023 | 6,758.00 |
| Sep 30, 2023 | 6,758.00 |